iShares Biotechnology ETF (IBB)
| 170.36 Delayed Data As of Sep 24 |  -3.56 / -2.05%Today’s Change | 128.23 Today|||52-Week Range 177.37 | +12.46% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years Sep 23 / MotleyFool.com - Paid Partner Content | Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News Sep 12 / Zacks.com - Paid Partner Content |
| Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Sep 15 / Zacks.com - Paid Partner Content |
Performance
| 1 month | +1.13% | 3 years | +13.81% | |
| 3 months | +8.39% | 5 years | +12.09% | |
| 1 year | +31.92% | Since inception | +8.51% |
Data through 09/24/2021
Quote Details
| Previous close | $173.92 |
| Open day’s range | 170.15 – 173.02 |
| Net asset value (NAV) | 173.95 (09/23/2021) |
| Daily volume | 138,779 |
| Average volume (3 months) | 2,832,868 |
Data as of 4:32pm ET, 09/24/2021
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +12.09% | +15.71% |
| Expense Gross exp ratio | 0.45% | 1.01% |
| Risk 5 year sharpe ratio | 0.65 | 0.83 |
| Net assets | $11.3B | $2.6B |
| Average market cap | $24.9B | $39.0B |
| Average P/E | 26.3 | 27.2 |
| Dividend / Share | -- | 0.29% |
Competitors
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| RYH Invesco S&P 500® Equal Weight Health Ca... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| MRNA Moderna Inc | 9.28% |
| AMGN Amgen | 6.93% |
| GILD Gilead Sciences | 6.57% |
| REGN Regeneron Pharmaceuticals | 4.90% |
| ILMN Illumina Inc | 4.79% |
| BNTX BioNTech SE | 4.19% |
| VRTX Vertex Pharmaceuticals Inc | 3.73% |
| BIIB Biogen | 3.67% |
| IQV IQVIA Holdings Inc | 3.55% |
| MTD Mettler-Toledo International Inc | 2.56% |
